rabbit slit3 pab Search Results


93
ABclonal Biotechnology slit3
Fig. 5. <t>SLIT3</t> was a direct target of miR-148a-5p. (A) Venn diagram of the intersection of miR-148a-5p screened by miRDB and mirDIP databases. (B) Venn diagram of the intersection of potential genes regulated by hUC-MSCs and target genes of miR-148a-5p. (C) Luciferase activity assay on LX2 cells co-transfected with SLIT3 WT 3′ UTR-luciferase plasmid or SLIT3 MUT 3′ UTR-luciferase plasmid and miR-148a-5p mimics or miR-148a-5p NC. (D) The expression levels of SLIT3 in LX2 cells transfected with miR-148a-5p mimics. (E) The protein level of Col1α1 and α-SMA in LX2 cells co-treated with miR-148a-5p mimic and pcDNA-SLIT3.
Slit3, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+slit3+pab/SLIT1+Rabbit+pAb/pm37918086-90-68-67
Average 93 stars, based on 1 article reviews
slit3 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


Fig. 5. SLIT3 was a direct target of miR-148a-5p. (A) Venn diagram of the intersection of miR-148a-5p screened by miRDB and mirDIP databases. (B) Venn diagram of the intersection of potential genes regulated by hUC-MSCs and target genes of miR-148a-5p. (C) Luciferase activity assay on LX2 cells co-transfected with SLIT3 WT 3′ UTR-luciferase plasmid or SLIT3 MUT 3′ UTR-luciferase plasmid and miR-148a-5p mimics or miR-148a-5p NC. (D) The expression levels of SLIT3 in LX2 cells transfected with miR-148a-5p mimics. (E) The protein level of Col1α1 and α-SMA in LX2 cells co-treated with miR-148a-5p mimic and pcDNA-SLIT3.

Journal: International immunopharmacology

Article Title: Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p/SLIT3 axis.

doi: 10.1016/j.intimp.2023.111134

Figure Lengend Snippet: Fig. 5. SLIT3 was a direct target of miR-148a-5p. (A) Venn diagram of the intersection of miR-148a-5p screened by miRDB and mirDIP databases. (B) Venn diagram of the intersection of potential genes regulated by hUC-MSCs and target genes of miR-148a-5p. (C) Luciferase activity assay on LX2 cells co-transfected with SLIT3 WT 3′ UTR-luciferase plasmid or SLIT3 MUT 3′ UTR-luciferase plasmid and miR-148a-5p mimics or miR-148a-5p NC. (D) The expression levels of SLIT3 in LX2 cells transfected with miR-148a-5p mimics. (E) The protein level of Col1α1 and α-SMA in LX2 cells co-treated with miR-148a-5p mimic and pcDNA-SLIT3.

Article Snippet: The membrane was subsequently blocked by immersion in a solution containing 5% skim milk in Tris-buffered saline containing Tween-20 for 1 h. The membranes were then exposed to primary antibodies and incubated overnight at a temperature of 4 ◦C: α-SMA (A17910, 1:1000, ABclonal), Col1a1 (ab138492, 1:1,000, Abcam), CD9 M. Yuan et al. International Immunopharmacology 125 (2023) 111134 (20597-1-AP, 1:2,000, Proteintech), CD81 (27855-1-AP, 1:2,000, Proteintech), TSG101 (A2216, 1:1,000, Abclonal), SLIT3 (DF9909, 1:1000, Affinity), and GAPDH (ab9485, 1:2,500, Abcam).

Techniques: Luciferase, Activity Assay, Transfection, Plasmid Preparation, Expressing

Fig. 6. Downexpression of SLIT3 significantly inhibits the activation of LX2 cells. (A) The expression levels of SLIT3 in our RNA-seq data. (B-D) The expression levels of SLIT3 in mouse liver tissues and cell samples. (E-H) The expression level of SLIT3 in the exogenous dataset (GSE130129, GSE38648, GSE149508, and GSE68001, respectively). (I-J) Single-cell data for SLIT3 were explored in single-cell RNA-seq analyses of human liver tissues from GSE136103 (n = 5 healthy and n = 5 cirrhotic). (K) GO analysis of similar/interactive genes of SLIT3 in Metascape database. (L) GSEA analysis based on the high- and low-SLIT3 expression groups in liver fibrosis (GSE84044). (M) The expression level of Col1α1 and α-SMA after knockdown in LX2 cells by siRNAs (si-SLIT3 and si-NC) for 48 h.

Journal: International immunopharmacology

Article Title: Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p/SLIT3 axis.

doi: 10.1016/j.intimp.2023.111134

Figure Lengend Snippet: Fig. 6. Downexpression of SLIT3 significantly inhibits the activation of LX2 cells. (A) The expression levels of SLIT3 in our RNA-seq data. (B-D) The expression levels of SLIT3 in mouse liver tissues and cell samples. (E-H) The expression level of SLIT3 in the exogenous dataset (GSE130129, GSE38648, GSE149508, and GSE68001, respectively). (I-J) Single-cell data for SLIT3 were explored in single-cell RNA-seq analyses of human liver tissues from GSE136103 (n = 5 healthy and n = 5 cirrhotic). (K) GO analysis of similar/interactive genes of SLIT3 in Metascape database. (L) GSEA analysis based on the high- and low-SLIT3 expression groups in liver fibrosis (GSE84044). (M) The expression level of Col1α1 and α-SMA after knockdown in LX2 cells by siRNAs (si-SLIT3 and si-NC) for 48 h.

Article Snippet: The membrane was subsequently blocked by immersion in a solution containing 5% skim milk in Tris-buffered saline containing Tween-20 for 1 h. The membranes were then exposed to primary antibodies and incubated overnight at a temperature of 4 ◦C: α-SMA (A17910, 1:1000, ABclonal), Col1a1 (ab138492, 1:1,000, Abcam), CD9 M. Yuan et al. International Immunopharmacology 125 (2023) 111134 (20597-1-AP, 1:2,000, Proteintech), CD81 (27855-1-AP, 1:2,000, Proteintech), TSG101 (A2216, 1:1,000, Abclonal), SLIT3 (DF9909, 1:1000, Affinity), and GAPDH (ab9485, 1:2,500, Abcam).

Techniques: Activation Assay, Expressing, RNA Sequencing, Knockdown